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AbstrAct
Objective Discrepancies in illness representations 
between patients and physicians result in treatment 
difficulties, decreased well-being of patients and 
misunderstandings and disrupted communication. 
Hence, the objective of this study was to compare illness 
perceptions of individual patients with systemic lupus 
erythematosus (SLE) and systemic sclerosis (SSc), their 
rheumatologists and their general practitioners (GPs) and 
explore potential differences.
Methods This study has a cross-sectional design. 
Patients with SLE and SSc, who were followed at the 
rheumatology department of the University Hospitals 
Leuven (Belgium), completed the revised Illness 
Perception Questionnaire which measures patients’ 
perceptions of their condition and captures nine 
dimensions. Physicians completed the Revised Illness 
Perception Questionnaire for Healthcare Professionals 
which consists of seven dimensions and measures 
perceptions of the healthcare professional regarding 
the disease of their patients. Intraclass correlation was 
performed to examine relationships between pairs of 
respondents; Cohen’s d was used for estimating the 
magnitude of the difference.
Results Questionnaires were sent to 284 patients 
of whom 241 (113 SSc and 128 SLE patients) were 
included. Five rheumatologists and 160 GPs participated. 
For both diseases, positive correlations were found for 
‘consequences’, ‘illness coherence’ and ‘emotional 
representations’ among patients, rheumatologists and 
GPs. GPs scored higher on the ‘consequences’ of these 
diseases for the patient (d=0.71 for SLE; d=0.80 for SSc). 
Differences between rheumatologists and GPs were small 
for SSc and moderate to large for ‘consequences’ (d=0.56) 
and ‘timeline acute/chronic’ (d=0.95) in SLE with higher 
scores for GPs.
Conclusions For both diseases and among the three 
groups, significant correlations are detected for the 
dimensions ‘consequences’, ‘illness coherence’ and 
‘emotional representations’. Differences between 
rheumatologists and GPs were mainly detected in the 
case of SLE patients. This can have implications for the 
collaboration between these two groups of physicians in 
daily clinical practice.
Clinical trial registration NCT02655640; Pre-results.
IntROduCtIOn
Systemic lupus erythematosus (SLE) and 
systemic sclerosis (SSc) are severe and 
complex chronic autoimmune diseases char-
acterised by multiple-organ involvement, a 
heterogeneous presentation and an unpre-
dictable disease course often leading to 
important morbidity and mortality.1 2 Both 
diseases can have an important impact on 
patients’ quality of life and the ability to carry 
out activities at home or at work due to pain, 
decreased physical functioning, fatigue and 
dyspnoea.3–6 These progressive or recurrent 
symptoms might influence the perceptions 
patients have about their condition.
Ideas about illness are an essential part of 
the self-regulation model, which proposes that 
behaviour in relation to illness depends on an 
individual’s perception or representation of 
his/her condition. In this model, Leventhal 
and colleagues7 postulated that illness repre-
sentations consist of five elements: identity 
(symptoms), cause, consequences (effects 
on life), timeline (duration) and control-
lability or cure of the condition. Studies in 
patients with SLE have demonstrated that 
illness perceptions are related to outcomes 
such as changes in psychological well-being 
over time,8 sexual (dys)functioning,9 (non-)
adherence to therapy10 and in those with 
SSc to physical and mental health but not 
to disease-related characteristics.11 12
Most studies only focus on patients’ illness 
perceptions and their association with clinical 
or patient-related outcomes,13 but the extent 
to which healthcare providers’ ideas about 
the consequences of a chronic disease in 
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specific patients match with those expressed by individual 
patients is unknown. This could be important because 
the management of SLE and SSc requires a therapeutic 
relationship between patients and providers over years, 
which makes adequate healthcare a joint responsibility of 
both providers and patients. Moreover, it is possible that 
because of this relationship for years, physicians’ percep-
tions can be influenced by patients and vice versa.
In one of the first studies14 describing beliefs about 
arthritis in patients and physicians (most of them were 
rheumatologists), differences were detected about what 
physicians think patients believe and what patients actu-
ally believe about causes of arthritis or what helps in 
arthritis. In a study about epilepsy and seizure disorders, 
there were differences between the illness perceptions of 
patients and their doctors, especially about the controlla-
bility of the condition, which could represent barriers to 
successful clinical management.15 In another study about 
breast cancer,16 medical professionals’ perceptions of the 
consequences of treatment and duration of cancer did not 
match patients’ beliefs: oncology nurses underestimated, 
whereas radiation therapists overestimated the impact of 
treatment and perceived duration of the disease. A study 
in osteoarthritis and diabetes showed that incongruence 
in patients and general practitioners’ (GPs’) perceptions 
regarding stressors accompanying chronic disease is 
larger in diseases with a less clear treatment policy and 
may influence healthcare use and physical and mental 
functioning.17
So, detecting discrepancies between healthcare 
providers and patients is of utmost importance because 
these may lead to problems in treatment, decreased well-
being of patients18 and misunderstandings and disrupted 
communication.17 19 20 Differences in illness perceptions 
among patients with systemic autoimmune diseases, rheu-
matologists and GPs are likely to be relevant because the 
knowledge and disease-related experience of these three 
groups is different. This is the first study to investigate 
these differences and to attempt a direct comparison 
between physicians and particular patients with SLE and 
SSc they care for. Hence, the aim of this study was to inves-
tigate similarities and differences in illness perceptions of 
individual patients with SLE and SSc with that of their 
rheumatologists and GPs.
MethOds
design
The present study has a cross-sectional design. However, 
it was part of a larger longitudinal project in patients with 
SLE and SSc. This study has been registered in  clinical-
trials. gov with ID number NCT02655640. The data for 
the current evaluation were those collected at baseline 
between November 2015 and February 2016.
study population
The study population consisted of patients, rheumatolo-
gists and GPs. A total of 284 patients with SLE and SSc, 
who were in follow-up at the University Hospitals Leuven 
(Belgium) and fulfilled the inclusion criteria, were 
approached and invited for participation. The inclusion 
criteria were as follows: the patient’s medical and cogni-
tive condition allows him/her to complete question-
naires; the patient has no severe psychiatric problems; 
the patient is proficient in Dutch and able to complete 
the questionnaires in Dutch. The five rheumatologists 
who were asked for participation worked at the systemic 
diseases care programme at the rheumatology depart-
ment of the University Hospitals Leuven. In addition to 
the rheumatologists, the patients’ GPs were also asked to 
participate.
Procedure
Patients received a letter with information about the 
goal of the study, a questionnaire pack and an informed 
consent form together with a prestamped envelope. 
Patients were asked to complete the informed consent 
and the questionnaire pack and return it within 2 weeks.
After the patients gave informed consent, the 
treating rheumatologist and GP of each patient were 
approached. The physicians were asked to fill out an 
illness perception questionnaire developed for health-
care professionals after completing an informed consent 
form. While completing the questionnaire, they had to 
rely on the most recent medical and psychosocial situ-
ation of the patient. The physicians were requested to 
complete the questionnaires as soon as possible after 
the patient consulted them. A maximum interval of 
6 months between the consultation of the patient and 
completion of the questionnaire by the physician was 
allowed. Additionally, for both patients and physicians, 
three reminders were sent after 3, 5 and 7 weeks. After 9 
weeks, patients were contacted by telephone if they were 
persistent non-responders.
Measures
Demographic characteristics
Age, gender, educational level, employment status, social 
status and living situation were collected from SLE and 
SSc patients (see table 1).
Clinical data
Disease duration and disease activity were measured. In 
SLE patients, disease activity was assessed by the Systemic 
Lupus Erythematosus Disease Activity Index (SLEDAI) 
score with the Safety of Estrogens in Lupus Erythema-
tosus National Assessment (SELENA) modification (ie, 
SELENA-SLEDAI).21 The SLEDAI is a valid and reliable 
index, which measures disease activity within the last 10 
days22 including 24 weighted objective clinical and labo-
ratory variables. Disease activity can range from 0 to 105. 
The following activity categories have been defined on 
the basis of SLEDAI scores: no activity (SLEDAI 0), mild 
activity (SLEDAI 1–5), moderate activity (SLEDAI 6–10), 
high activity (SLEDAI 11–19) and very high activity 
(SLEDAI ≥20).23
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In SSc patients, the SSc disease activity index (2003)24 
was used for measuring disease activity. This is a prelimi-
nary validated index to assess disease activity in SSc which 
consists of clinical and laboratory measures of disease 
activity as well as measures of disease activity being assessed 
by the patient only. It captures 10 weighted measures, and 
the scores have a range from 0 to 10. SSc is considered to 
be active if the disease activity is ≥3.
Illness perceptions of patients and physicians
Patients completed the Dutch version25 of the revised 
Illness Perception Questionnaire (IPQ-R) developed by 
Moss-Morris and colleagues.26 This questionnaire meas-
ures perceptions of patients regarding their disease and 
consists of nine dimensions or subscales: an illness iden-
tity dimension, seven illness perception subscales and a 
causal attributions dimension. It has demonstrated good 
reliability and validity across several illness groups and is 
one of the most widely applied instruments for assessing 
perceptions about illness.27
For the purpose of this study, we only used the seven 
illness perception subscales (38 items) that include views 
about how long the disease will last (timeline acute/
chronic), the recurrent nature of the condition (time-
line cyclical), perceived consequences of the condition, 
perceptions of personal control and treatment control, 
patient’s overall illness comprehension (illness coher-
ence) and emotional representations. The items for all 
subscales are rated by the patient on a 5-point Likert scale 
from 1 (‘strongly disagree’) to 5 (‘strongly agree’). Scores 
were calculated as the sum of the items per scale (as in the 
original publication).
The physicians completed the Revised Illness Percep-
tion Questionnaire for Healthcare Professionals (IPQ-R 
HP).28 The IPQ-R HP28 is an adapted version of the IPQ-R26 
Table 1 Demographic and clinical characteristics of patients
Systemic sclerosis (n=113)
Systemic lupus 
erythematosus (n=128)
Gender
  Women n=76 (67.3%) n=123 (96.1%) 
Age in years, mean (SD) 60.17 (10.82) 46.28 (14.97)
Social status, n (proportion)
  Married
  Cohabitation
  Single
  Divorced
  Widow
  Other
83 (73.5%)
3 (2.7%)
8 (7.1%)
12 (10.6%)
7 (6.2%)
 
78 (60.9%)
23 (18.0%)
11 (8.6%)
9 (7.0%)
5 (3.9%)
2 (1.6%)
Living situation, n (proportion)
  Living alone
  Cohabitation with partner and kids
  Cohabitation with partner
  Cohabitation with kids
  Cohabitation with friends
  Other
20 (17.7%)
24 (21.2%)
59 (52.2%)
4 (3.5%)
3 (2.7%)
2 (1.8%)
16 (12.5%)
46 (35.9%)
53 (41.4%)
6 (4.7%)
7 (5.5%)
 
Education, n (proportion)
  Primary school
  Secondary school
  Bachelor degree
  Master degree
21 (18.6%)
68 (60.2%)
17 (15.0%)
7 (6.2%)
10 (7.8%)
58 (45.3%)
41 (32.0%)
18 (14.1%)
Work status, n (proportion)
  Full-time
  Part-time because of illness
  Part-time (personal choice)
  Retired
  Student
  Unemployed
  Disablement benefit
  Sickness benefit
  Other
14 (12.4%)
7 (6.2%)
3 (2.7%)
49 (43.4%)
 
2 (1.8%)
18 (15.9%)
8 (7.1%)
12 (10.6%)
33 (25.8%)
13 (10.2%)
16 (12.5%)
20 (15.6%)
6 (4.7%)
4 (3.1%)
24 (18.8%)
2 (1.6%)
10 (7.8%)
Disease duration (mean±SD) 8.48±9.14 years 13.90±9.31 years
Disease activity (mean±SD) 1.51±1.49 3.40±3.27
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which is devised to be completed by healthcare profes-
sionals. It is a 38-item questionnaire rated on a 5-point 
Likert scale from 1 (‘strongly disagree’) to 5 (‘strongly 
agree’) and consists of the same seven dimensions as 
described above. The key characteristic of the IPQ-R HP 
is that healthcare professionals are asked to indicate what 
they think what the perceptions of the particular patient 
are. Sample items read as: ‘The illness of my patient has 
major consequences on his/her life’; ‘The illness of my 
patient will last for a long time’; or ‘The symptoms of the 
condition of my patient are puzzling to him/her’.
statistical analysis
Sociodemographic variables, clinical variables and self-re-
ported data from the questionnaires were summarised 
using descriptive statistics such as frequencies, means 
and SDs. To check the normality of the data, the Kolmog-
orov-Smirnov test was used.
Intraclass correlation was performed to examine agree-
ment among the three groups of respondents regarding 
the seven illness perception dimensions: rheumatologists 
and their patients, GPs and their patients, and rheuma-
tologists and GPs. Cut-off values for the intraclass correla-
tion are trivial <0.1, small 0.1–0.29, moderate 0.3–0.49, 
large 0.5–0.69, very large 0.7–0.89, almost perfect >0.9.29
A paired t-test was conducted to detect differences in 
these seven dimensions among the three pairs of respon-
dents as described above. The choice for a paired t-test 
was made on the basis of the distribution of the data and 
the link between patients and physicians and rheumatol-
ogists and GPs.
In addition, to appraise the magnitude of potential 
differences in perceptions between the groups, Cohen’s 
d was calculated to estimate how large the difference was 
between the mean scores on the dimensions for each 
group. The cut-off values for Cohen’s d are as follows: 
small 0.20–0.50, medium 0.50–0.80 and large ≥0.80.30
Analyses were carried out with SPSS V.24.0 (SPSS, 
Chicago, Illinois, USA).
ethical approval
Ethical approval was obtained from the institutional 
review board of the University Hospitals Leuven (ID no. 
B322201526067).
Results
Respondents
Questionnaires were sent to 284 patients who fulfilled 
the inclusion criteria, 241 of which participated (113 SSc 
patients and 128 SLE patients). The five rheumatologists 
and GPs of these patients were also asked to participa-
teasked for participation. The rheumatologists completed 
together a total of 229 questionnaires. A total of 240 
GPs received questionnaires, 160 of which returned 
completed questionnaires (response rate 66.7%) (see 
figure 1 for detailed information). The demographic and 
clinical information of the patients is shown in table 1.
The group of the rheumatologists consisted of 
two women and three men. The group of the GPs 
consisted of 99 men and 61 women. The gender distribu-
tion in the group of the non-responders was comparable 
to that of the responders (60.0% vs 61.9%). No informa-
tion on other characteristics was available.
Comparisons among illness representations of sle patients, 
their rheumatologists and their GPs
Between patients and rheumatologists, a large positive 
intraclass correlation was found for the perceived conse-
quences of SLE. Moderate intraclass correlations were 
observed for controllability by treatment, illness coher-
ence and the emotional impact of SLE (see table 2). 
Looking at the Cohen’s d, differences between patients 
and their rheumatologists were futile or small for all 
dimensions, except for timeline cyclical, on which the 
patients scored higher with a moderate difference.
Between patients and GPs, moderate positive correla-
tions were found for the perceived consequences, illness 
coherence and the emotional impact of SLE. A moder-
ately large difference was found for consequences, on 
which GPs scored higher than their patients.
Between rheumatologists and GPs, moderate but statisti-
cally significant correlations were found for the perceived 
consequences, chronicity of the time course, illness 
coherence and the emotional impact of SLE. For conse-
quences, the difference in mean score was moderate, with 
higher scores in GPs than in rheumatologists, and for 
timeline acute/chronic, the difference was large.
Comparisons between illness representations of ssc patients, 
their rheumatologists and their GPs
Also for SSc, moderate positive intraclass correlations 
were found between patients and rheumatologists on 
the consequences dimension, illness coherence and 
emotional representations (see table 3). Patients scored 
lower in comparison with rheumatologists, with a 
moderate difference for the consequences dimension.
Figure 1 Flow diagram of inclusion procedure of patients 
and physicians.
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Between patients and GPs, moderate positive correla-
tions were found for consequences and illness coherence 
and large intraclass correlations for personal control. 
Patients had lower mean scores on the perceived conse-
quences with a large difference for consequences and 
moderate difference for timeline acute/chronic and 
illness coherence.
Between rheumatologists and GPs, large positive 
correlations were found for the perceived consequences; 
and moderate correlations, for personal control, illness 
coherence and the emotional impact of SSc. A large differ-
ence was found for consequences, on which GPs scored 
higher than patients. For timeline acute/chronic and 
treatment control, a moderate difference was found with 
also higher scores for GPs than patients. The detected 
differences between rheumatologists and GPs were small 
for all dimensions.
dIsCussIOn
The aim of this paper was to explore commonalities and 
differences in perceptions among patients with SLE and 
SSc, their rheumatologists and their GPs on the individual 
representations of their illness.
For both diseases, we found moderate to large correla-
tions in the consequences, illness coherence and 
emotional representations dimension among patients, 
rheumatologists and GPs. The GPs scored higher on 
these dimensions in comparison with the patients, but the 
difference was mostly small to moderate. They seemed to 
overestimate the consequences of these diseases for the 
patient, the understanding of these diseases by the patient 
and the emotional impact for SLE patients but not for SSc 
patients. Our results are in concordance with a number 
of studies in epilepsy15 31 32 in which the neurologists 
score higher on the aforementioned dimensions than the 
patients. The rheumatologists scored also higher on these 
dimensions than the patients, but the differences were 
mostly small. Except in SLE, patients had the perception 
of a more recurrent time course than rheumatologists. 
This difference was moderate.
A closer look at comparisons between rheumatologists 
and GPs shows that, for SLE, GPs have higher scores on 
consequences, illness coherence, timeline acute/chronic 
and emotional representations and, for SSc, rheumatol-
ogists score higher than the GPs on these dimensions 
(except for illness coherence). This reflects that GPs 
consider SLE to be a much more severe condition than 
rheumatologists and patients do. This could be attributed 
to lack of knowledge or the fact that they rely on general 
information about SLE—for instance, coming from text-
books, which tend to put too much emphasis on severe 
SLE manifestations—when scoring the questionnaire.
For SSc, moderate to large correlations were found for 
personal control in both patients and GPs and GPs and 
rheumatologists. The difference between these groups 
was statistically small but can have clinical implications. 
The fact that there is a difference can be related to the 
rarity of SSc and interpatient differences, both in the type 
of controllable symptoms and the level of control,33 and 
that personal control is a construct of illness perceptions 
which is the most complex and multifactorial in relation 
to the other dimensions.34 Another explanation is that 
GPs might have lack of knowledge or limited patient 
contact and therefore rely more on the information 
provided by the patient. This emphasises the importance 
of the collaboration between GPs and rheumatologists 
for receiving and providing up-to-date disease-related 
information. In daily clinical practice, perceived control 
is based on knowledge about the disease—for instance, 
provided by a healthcare professional—and also on 
the patients’ personal experience. This dimension is 
important because of several reasons. The first reason is 
that personal control is one of the dimensions that predicts 
outcomes and is easily changeable with interventions. 
Much more than the other dimensions, personal control 
can be altered by patient education sessions and self-man-
agement programs.35–37 Dedicated educational programs 
with an emphasis on the perceptions of patients, initi-
ated by physicians, could reduce the knowledge deficit 
in the patients. Also, as the GP often remains the primary 
caregiver, it is crucial that the illness perceptions of both 
GP and rheumatologists are aligned. For this, commu-
nication modalities between these two groups of health 
professionals should be optimised.
The strengths of this study are that we had dyads of 
patients, rheumatologists and GPs and a high response 
rate. The number of GPs that participated was consider-
able. The study setting was a large university hospital in 
Belgium. The results of this study should be interpreted 
in light of some methodological limitations. A small 
number of GPs sent us a blank questionnaire with a note 
that they did not want to complete the IPQ-R HP because 
the patient visited them too long ago or not frequently 
so that they did not feel comfortable to judge in detail 
the patient’s health situation. Another limitation is 
that the rheumatologists who completed the IPQ-R HP 
mentioned that completing the questionnaire was not 
always easy. Some dimensions such as timeline acute/
chronic, treatment control and personal control were 
mainly based on medical knowledge. Other dimensions 
such as the emotional representations and illness coher-
ence were completed much more subjectively by putting 
themselves in place of the patient. So, the set-up of the 
IPQ-R HP needs further exploration.
Another point for consideration is the external 
validity of the study results. This study has been 
conducted in a large single centre which implies that 
the generalisability can be limited. Furthermore, the 
current study has a cross-sectional design which implies 
that it cannot establish the directionality of the asso-
ciations between rheumatologists or GPs and patients. 
It is possible that the physicians’ perception is influ-
enced by the way a patient perceives and reports his 
condition or vice versa. Other implications for further 
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research are that the uncovered differences in illness 
perceptions between patients and medical staff can now 
be studied for their impact on outcomes. The current 
study provides insights in illness perception dimensions 
that are important for inclusion in future research 
about the influence of illness perceptions on outcomes 
such as patient satisfaction, adherence, healthcare util-
isation and others.
In conclusion, we can state that for both diseases 
and among patients, rheumatologists and GPs, signif-
icant correlations in illness perceptions are detected 
for the dimensions consequences, illness coherence 
and emotional representations. For SLE, we found that 
GPs perceived the consequences of SLE as more severe 
than patients and rheumatologists do and that GPs also 
perceived SLE as more chronic than rheumatologists. 
GPs perceived SSc as more severe, chronic and control-
lable by treatment than patients. These differences can 
have implications for the communication and collabora-
tion in daily clinical practice.
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